CLINICAL_TRIALS
trial_result
· 2013-07-15
Clinical Trial Update: Bioequivalence Study of Albendazole 400 mg Tablets in Chinese Population [Phase 1]
Summary
A Phase 1 bioequivalence trial of Albendazole 400 mg tablets conducted in Chinese participants; results comparing pharmacokinetics were posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Helminthiasis | Phase 1 | Status: COMPLETED | Results posted: 2013-07-15